These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 23159714

  • 1. Levetiracetam in children, adolescents and young adults with intractable epilepsy: efficacy, tolerability and effect on electroencephalogram--a pilot study.
    Goldberg-Stern H, Feldman L, Eidlitz-Markus T, Kramer U, Perez S, Pollak L, Phatal-Valevski A.
    Eur J Paediatr Neurol; 2013 May; 17(3):248-53. PubMed ID: 23159714
    [Abstract] [Full Text] [Related]

  • 2. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM, Arts WF, ten Houten R, Augustijn P, Gunning WB, Peeters EA, Weber AM, Stroink H, Geerts Y, Geerts AT, Brouwer OF.
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [Abstract] [Full Text] [Related]

  • 3. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS, Kothare SV, Valencia I, Melvin JJ, Legido A.
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [Abstract] [Full Text] [Related]

  • 4. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial.
    Lagae L, Buyse G, Ceulemans B.
    Seizure; 2005 Jan; 14(1):66-71. PubMed ID: 15642504
    [Abstract] [Full Text] [Related]

  • 5. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 6. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N, Jones J, Tonner F.
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [Abstract] [Full Text] [Related]

  • 7. Continuation rates of levetiracetam in children from the EULEVp cohort study.
    Dureau-Pournin C, Pédespan JM, Droz-Perroteau C, Lavernhe G, Mann M, Pollet C, Robinson P, Jové J, Moore N, Fourrier-Réglat A, EULEV study group.
    Eur J Paediatr Neurol; 2014 Jan; 18(1):19-24. PubMed ID: 24035600
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M, Pong AW.
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
    Lee YJ, Kang HC, Kim HD, Lee JS.
    Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience.
    Kluger G, Kurlemann G, Haberlandt E, Ernst JP, Runge U, Schneider F, Makowski C, Boor R, Bast T.
    Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229
    [Abstract] [Full Text] [Related]

  • 11. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
    Kinirons P, McCarthy M, Doherty CP, Delanty N.
    Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
    [Abstract] [Full Text] [Related]

  • 12. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 13. Levetiracetam as add-on therapy in generalised epilepsies.
    Kumar SP, Smith PE.
    Seizure; 2004 Oct; 13(7):475-7. PubMed ID: 15324824
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
    Valencia I, Piñol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A.
    Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
    [Abstract] [Full Text] [Related]

  • 15. Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.
    Brodtkorb E, Klees TM, Nakken KO, Lossius R, Johannessen SI.
    Epilepsy Behav; 2004 Apr; 5(2):231-5. PubMed ID: 15123025
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [Abstract] [Full Text] [Related]

  • 19. [Clinical experience with levetiracetam for adults with epilepsy].
    Barcs G, Szucs A.
    Ideggyogy Sz; 2007 Jan 20; 60(1-2):31-4. PubMed ID: 17432091
    [Abstract] [Full Text] [Related]

  • 20. The long-term efficacy and safety of levetiracetam in a tertiary epilepsy centre.
    Kang BS, Moon HJ, Kim YS, Lee ST, Jung KH, Chu K, Lee SK.
    Epileptic Disord; 2013 Sep 20; 15(3):302-10. PubMed ID: 23981665
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.